GET 15% OFF FIRST SUBSCRIPTION ORDER (CLICK FOR DETAILS)

N-ACETYL-L-TYROSINE BENEFITS

KEY BENEFITS OF N-ACETYL-L-TYROSINE

    • Supports working memory, mental flexibility, and information processing
    • Supports a healthy stress response

    • Supports skin health

      • Supports brain function

    • Supports adaptation to stressful circumstances

ABOUT IS N-ACETYL-L-TYROSINE

N-acetyl-L-tyrosine (NALT) is a type of acetylated L-tyrosine. NALT (along with L-tyrosine) acts as a precursor to the neurotransmitter dopamine, so it is used as a nootropic.

 

There is a strong link between dopamine and reward, motivation, and pleasure, and it is an essential neurotransmitter in modulating focus, motivation, cognitive flexibility, and emotion.

 

Besides being a key regulator of creative-productive powers and states, dopamine is also a key regulator of motor control and coordination, so it is also crucial for muscle strength and performance.

 

When performing more demanding or stressful tasks[1], NALT (or other sources of L-tyrosine) may be particularly useful for cognitive support.

 

One study found that oral NALT significantly increased L-tyrosine[2] levels in the brain.

N-ACETYL-L-TYROSINE FULL BENEFITS

Brain function

 

  • Supports working memory[13–19]

  • Supports cognitive flexibility[20]

  • Supports logical reasoning[14]

  • Supports mathematical processing[14]

  • Supports convergent ("deep") thinking—a component of creativity[21]

  • Supports perceptual-motor task performance[15,22]

  • Supports inhibition of behavioral responses—a cognitive control function[23]

  • Precursor for catecholamine synthesis [dopamine, noradrenaline, and adrenaline][4]

  • Supports the rate of dopamine synthesis and release upon neuronal activation[5–10]

  • Supports norepinephrine synthesis and release upon neuronal activation[10–12]

  • Protects from neurotransmitter (DA, NE) depletion due to increased brain activity[1]

  • Protects from performance decline during cognitively demanding tasks[1]

 

Stress

 

  • Protects from the negative effects of stress on cognitive performance[15–18,22]

  • Protects from adverse behavioral responses to environmental stress[24]

  • Protects from stress-induced decreases in norepinephrine levels[25]

  • Protects from stress-induced increases in blood pressure[15,22]

  • Supports global mood[26]

N-ACETYL-L-TYROSINE CAN BE FOUND IN:

Morning Momentum

Get Instant Access To A Simple, Proven System That Has Helped

THOUSANDS of People

IGNITE Their Health and Energy

to Create The Life They Deserve!

Learn More

START HERE

 

OPTIMUM MIND PERFORMANCE

 

Optimum Health (Foundation)

 

Cleanse, Clear & Rejuvenate

 

Internal Body Balance

 

Build Healthy Cells

 

Fuel Your Mind & Body

 

Protect: Longevity & Immunity

 

Enhance: Biohacking

REFERENCES

[1] B.J. Jongkees, B. Hommel, S. Kühn, L.S. Colzato, J. Psychiatr. Res. 70 (2015) 50–57.
[2] G. Topall, H. Laborit, J. Pharm. Pharmacol. 41 (1989) 789–791.
[3] S.C. Daubner, T. Le, S. Wang, Arch. Biochem. Biophys. 508 (2011) 1–12.
[4] J.D. Fernstrom, M.H. Fernstrom, J. Nutr. 137 (2007) 1539S–1547S; discussion 1548S.
[5] S.Y. Tam, J.D. Elsworth, C.W. Bradberry, R.H. Roth, J. Neural Transm. Gen. Sect. 81 (1990) 97–110.
[6] R.J. Wurtman, F. Larin, S. Mostafapour, J.D. Fernstrom, Science 185 (1974) 183–184.
[7] M.C. Scally, I. Ulus, R.J. Wurtman, J. Neural Transm. 41 (1977) 1–6.
[8] J.D. Milner, R.J. Wurtman, Neurosci. Lett. 59 (1985) 215–220.
[9] M.J. During, I.N. Acworth, R.J. Wurtman, J. Neurochem. 52 (1989) 1449–1454.
[10] T. Oishi, R.J. Wurtman, J. Neural Transm. 53 (1982) 101–108.
[11] S.K. Yeghiayan, S. Luo, B. Shukitt-Hale, H.R. Lieberman, Physiol. Behav. 72 (2001) 311–316.
[12] C.J. Gibson, R.J. Wurtman, Life Sci. 22 (1978) 1399–1405.
[13] L.S. Colzato, B.J. Jongkees, R. Sellaro, B. Hommel, Front. Behav. Neurosci. 7 (2013) 200.
[14] R.A. Magill, W.F. Waters, G.A. Bray, J. Volaufova, S.R. Smith, H.R. Lieberman, N. McNevin, D.H. Ryan, Nutr. Neurosci. 6 (2003) 237–246.
[15] J.B. Deijen, J.F. Orlebeke, Brain Res. Bull. 33 (1994) 319–323.
[16] C.R. Mahoney, J. Castellani, F.M. Kramer, A. Young, H.R. Lieberman, Physiol. Behav. 92 (2007) 575–582.
[17] C. O’Brien, C. Mahoney, W.J. Tharion, I.V. Sils, J.W. Castellani, Physiol. Behav. 90 (2007) 301–307.
[18] D. Shurtleff, J.R. Thomas, J. Schrot, K. Kowalski, R. Harford, Pharmacol. Biochem. Behav. 47 (1994) 935–941.
[19] J.R. Thomas, P.A. Lockwood, A. Singh, P.A. Deuster, Pharmacol. Biochem. Behav. 64 (1999) 495–500.
[20] L. Steenbergen, R. Sellaro, B. Hommel, L.S. Colzato, Neuropsychologia 69 (2015) 50–55.
[21] L.S. Colzato, A.M. de Haan, B. Hommel, Psychol. Res. 79 (2015) 709–714.
[22] J.B. Deijen, C.J. Wientjes, H.F. Vullinghs, P.A. Cloin, J.J. Langefeld, Brain Res. Bull. 48 (1999) 203–209.
[23] L.S. Colzato, B.J. Jongkees, R. Sellaro, W.P.M. van den Wildenberg, B. Hommel, Neuropsychologia 62 (2014) 398–402.
[24] L.E. Banderet, H.R. Lieberman, Brain Res. Bull. 22 (1989) 759–762.
[25] H. Lehnert, D.K. Reinstein, B.W. Strowbridge, R.J. Wurtman, Brain Res. 303 (1984) 215–223.
[26] L.A. Palinkas, K.R. Reedy, M. Smith, M. Anghel, G.D. Steel, D. Reeves, D. Shurtleff, H.S. Case, N. Van Do, H.L. Reed, Int. J. Circumpolar Health 66 (2007) 401–417.